Chinese Peptide Company, Subsidiary of Medtide Inc.: Tirzepatide API Successfully Secures US FDA DMF Filing, Fully Empowering the Global Weight Loss and Metabolism Arena

Good News | Medtide Inc.’s Subsidiary Chinese Peptide Company Sees Triptorelin Pamoate API Accepted for CDE Registration, Adding a New Product to Its Peptide Hormone Regulatory Portfolio

Medtide Inc. Awarded “Leading Enterprise” in the 2026 Forbes China Industry Development Pioneers Selection